Aquestive Therapeutics Newsroom

CRSP, NYMT and SBRA Are Among After Hour Movers

Seeking AlphaMay 17 17:05 ET

Aquestive Therapeutics Initiated at Outperform by Leerink Partners

Aquestive Therapeutics Initiated at Outperform by Leerink Partners

Dow JonesMay 10 15:09 ET

Express News | Leerink Partners Initiates Coverage On Aquestive Therapeutics With Outperform Rating, Announces Price Target of $8

BenzingaMay 10 15:00 ET

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

Aquestive Therapeutics (AQST) has an average rating of buy and price targets ranging from $5.50 to $13, according to analysts polled by Capital IQ.

MT NewswiresMay 10 07:11 ET

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 16:51 ET

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Last week, you might have seen that Aquestive Therapeutics, Inc. (NASDAQ:AQST) released its first-quarter result to the market. The early response was not positive, with shares down 5.9% to US$3.09 in

Simply Wall StMay 9 08:03 ET

Express News | HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target

BenzingaMay 9 07:21 ET

Aquestive Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 200% HC Wainwright & Co. → $9 Reiterates Buy → Buy 04/30/2024 200% HC Wainwright & Co. → $9 Rei

BenzingaMay 9 07:19 ET

Express News | Aquestive Therapeutics Inc : Alliance Global Partners Cuts Target Price to $5.5 From $7

ReutersMay 9 07:05 ET

Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ), MannKind (MNKD) and Aquestive Therapeutics (AQST)

TipRanksMay 9 06:50 ET

Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 9 03:05 ET

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)

TipRanksMay 8 12:20 ET

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)

TipRanksMay 8 09:01 ET

Express News | Aquestive Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results

BenzingaMay 8 08:49 ET

Aquestive Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

Aquestive Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

BenzingaMay 8 08:49 ET

Aquestive Therapeutics Presents to Investors and Analysts

TipRanksMay 8 06:13 ET

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Yahoo FinanceMay 7 19:00 ET

Aquestive Therapeutics Q1 2024 GAAP EPS $(0.17) Misses $(0.07) Estimate, Sales $12.053M Miss $12.262M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.07) by 142.86 percent. This is a 254.55 percent decrease over ear

BenzingaMay 7 17:48 ET

Express News | Aquestive Therapeutics Sees Full Year 2024 Non-Gaap Adjusted Ebitda Loss $22 Mln to $26 Mln

ReutersMay 7 17:03 ET

Express News | Aquestive Therapeutics Sees Full Year 2024 Total Revenue $48 Mln to $51 Mln

ReutersMay 7 17:03 ET